Search

fluoxetine vs 2,3,5-trifluorophenol

Input interpretation

fluoxetine | 2, 3, 5-trifluorophenol
fluoxetine | 2, 3, 5-trifluorophenol

Chemical names and formulas

 | fluoxetine | 2, 3, 5-trifluorophenol formula | C_17H_18F_3NO | F_3C_6H_2OH Hill formula | C_17H_18F_3NO | C_6H_3F_3O name | fluoxetine | 2, 3, 5-trifluorophenol IUPAC name | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | 2, 3, 5-trifluorophenol alternate names | deprex | fluval | prozac | (none) mass fractions | C (carbon) 66% | F (fluorine) 18.4% | H (hydrogen) 5.87% | N (nitrogen) 4.53% | O (oxygen) 5.17% | C (carbon) 48.7% | F (fluorine) 38.5% | H (hydrogen) 2.04% | O (oxygen) 10.8%
| fluoxetine | 2, 3, 5-trifluorophenol formula | C_17H_18F_3NO | F_3C_6H_2OH Hill formula | C_17H_18F_3NO | C_6H_3F_3O name | fluoxetine | 2, 3, 5-trifluorophenol IUPAC name | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | 2, 3, 5-trifluorophenol alternate names | deprex | fluval | prozac | (none) mass fractions | C (carbon) 66% | F (fluorine) 18.4% | H (hydrogen) 5.87% | N (nitrogen) 4.53% | O (oxygen) 5.17% | C (carbon) 48.7% | F (fluorine) 38.5% | H (hydrogen) 2.04% | O (oxygen) 10.8%

Structure diagrams

  | fluoxetine | 2, 3, 5-trifluorophenol vertex count | 22 | 10 edge count | 24 | 11 Schultz index | 4718 | 456 Wiener index | 1148 | 110 Hosoya index | 28544 | 82 Balaban index | 1.822 | 2.487
| fluoxetine | 2, 3, 5-trifluorophenol vertex count | 22 | 10 edge count | 24 | 11 Schultz index | 4718 | 456 Wiener index | 1148 | 110 Hosoya index | 28544 | 82 Balaban index | 1.822 | 2.487

3D structure

3D structure
3D structure

Basic properties

 | fluoxetine | 2, 3, 5-trifluorophenol molar mass | 309.33 g/mol | 148.08 g/mol phase | solid (at STP) | solid (at STP) melting point | 158 °C | 29 °C boiling point | | 57 °C density | | 1.457 g/cm^3 solubility in water | insoluble |
| fluoxetine | 2, 3, 5-trifluorophenol molar mass | 309.33 g/mol | 148.08 g/mol phase | solid (at STP) | solid (at STP) melting point | 158 °C | 29 °C boiling point | | 57 °C density | | 1.457 g/cm^3 solubility in water | insoluble |

Units

Hydrophobicity and permeability properties

 | fluoxetine experimental LogP hydrophobicity | 4.6 predicted LogP hydrophobicity | 4.1 predicted LogS | -5.26
| fluoxetine experimental LogP hydrophobicity | 4.6 predicted LogP hydrophobicity | 4.1 predicted LogS | -5.26

Drug interactions

fluoxetine | acenocoumarol | almotriptan | amitriptyline | amoxapine | amphetamine | anisindione | astemizole | atomoxetine | benzphetamine | carbamazepine | carvedilol | cilostazol | clarithromycin | clomipramine | clozapine | cyclosporin A | cyproheptadine | desipramine | dexfenfluramine | dextroamphetamine | ... (total: 71)
fluoxetine | acenocoumarol | almotriptan | amitriptyline | amoxapine | amphetamine | anisindione | astemizole | atomoxetine | benzphetamine | carbamazepine | carvedilol | cilostazol | clarithromycin | clomipramine | clozapine | cyclosporin A | cyproheptadine | desipramine | dexfenfluramine | dextroamphetamine | ... (total: 71)

Pharmacodynamics and pharmacokinetics

 | fluoxetine absorption | 72% protein binding | 94.5% biological half-life | 48 h lethal dosage LD_50 | 284 mg/kg biotransformation | hepatic
| fluoxetine absorption | 72% protein binding | 94.5% biological half-life | 48 h lethal dosage LD_50 | 284 mg/kg biotransformation | hepatic

Units